Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. Pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response

Overview

Journal Gut Liver

Specialty Gastroenterology

Date 2010 May 19

PMID 20479912

Citations 12

Authors

Yunjeong Jo

Sang Uk Han

Yoon Jae Kim

Ju Hyeon Kim

Shin Tae Kim

Seong-Jin Kim

Ki-Baik Hahm

Affiliations

Soon will be listed here.

Abstract

Background/aims: Loss of transforming growth factor beta1 (TGF-beta1) exhibits a similar pathology to that seen in a subset of individuals infected with Helicobacter pylori, including propagated gastric inflammation, oxidative stress, and autoimmune features. We thus hypothesized that gastric mucosal TGF-beta1 levels could be used to determine the outcome after H. pylori infection.

Methods: Northern blot for the TGF-beta1 transcript, staining of TGF-beta1 expression, luciferase reporter assay, and enzyme-linked immunosorbent assay for TGF-beta1 levels were performed at different times after H. pylori infection.

Results: The TGF-beta1 level was markedly lower in patients with H. pylori-induced gastritis than in patients with a similar degree of gastritis induced by nonsteroidal anti-inflammatory drugs. There was a significant negative correlation between the severity of inflammation and gastric mucosal TGF-beta1 levels. SNU-16 cells showing intact TGF-beta signaling exhibited a marked decrease in TGF-beta1 expression, whereas SNU-638 cells defective in TGF-beta signaling exhibited no such decrease after H. pylori infection. The decreased expressions of TGF-beta1 in SNU-16 cells recovered to normal after 24 hr of H. pylori infection, but lasted very spatial times, suggesting that attenuated expression of TGF-beta1 is a host defense mechanism to avoid attachment of H. pylori.

Conclusions: H. pylori infection was associated with depressed gastric mucosal TGF-beta1 for up to 24 hr, but this apparent strategy for rescuing cells from H. pylori attachment exacerbated the gastric inflammation.

Citing Articles

Traditional Chinese medicine in the treatment of -related gastritis: The mechanisms of signalling pathway regulations.

Zhang P, Li L, Qu H, Chen G, Xie M, Chen Y World J Gastroenterol. 2025; 31(3):96582.

PMID: 39839895 PMC: 11684169. DOI: 10.3748/wjg.v31.i3.96582.

Old and New Aspects of -Associated Inflammation and Gastric Cancer.

Dinca A, Melit L, Marginean C Children (Basel). 2022; 9(7).

PMID: 35884067 PMC: 9322908. DOI: 10.3390/children9071083.

A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing.

Yin H, Guo R, Zhang H, Liu S, Gong Y, Yuan Y Front Immunol. 2021; 12:728169.

PMID: 34745098 PMC: 8566821. DOI: 10.3389/fimmu.2021.728169.

Cytokine Secretion, Viability, and Real-Time Proliferation of Apical-Papilla Stem Cells Upon Exposure to Oral Bacteria.

Rakhimova O, Schmidt A, Landstrom M, Johansson A, Kelk P, Romani Vestman N Front Cell Infect Microbiol. 2021; 10:620801.

PMID: 33718256 PMC: 7945949. DOI: 10.3389/fcimb.2020.620801.

Arginase-1 and Treg Profile Appear to Modulate Inflammatory Process in Patients with Chronic Gastritis: May Be the Alarm Cytokine in -Positive Patients.

da Silva E, da Silva N, Rodrigues R, Adad S, Pereira S, Ribeiro B Mediators Inflamm. 2019; 2019:2536781.

PMID: 31320834 PMC: 6610761. DOI: 10.1155/2019/2536781.

References

Wilson K, Ramanujam K, Mobley H, Musselman R, James S, Meltzer S . Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology. 1996; 111(6):1524-33. DOI: 10.1016/s0016-5085(96)70014-8. View

Massague J, Attisano L, Wrana J . The TGF-beta family and its composite receptors. Trends Cell Biol. 1994; 4(5):172-8. DOI: 10.1016/0962-8924(94)90202-x. View

Davies G, Banatvala N, Collins C, Sheaff M, Abdi Y, Clements L . Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol. 1994; 29(5):419-24. DOI: 10.3109/00365529409096832. View

Ashcroft G, Dodsworth J, van Boxtel E, Tarnuzzer R, Horan M, Schultz G . Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997; 3(11):1209-15. DOI: 10.1038/nm1197-1209. View

Niv Y, Fraser G, Delpre G, Neeman A, Leiser A, Samra Z . Helicobacter pylori infection and blood groups. Am J Gastroenterol. 1996; 91(1):101-4. View

Gold L, Sung J, Siebert J, Longaker M . Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am J Pathol. 1997; 150(1):209-22. PMC: 1858519. View

Hentschel E, Brandstatter G, Dragosics B, Hirschl A, Nemec H, Schutze K . Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993; 328(5):308-12. DOI: 10.1056/NEJM199302043280503. View

Kirchner T, Steininger H, Faller G . Immunopathology of Helicobacter pylori gastritis. Digestion. 1997; 58 Suppl 1:14-6. DOI: 10.1159/000201516. View

Kuipers E, Klinkenberg-Knol E, Vandenbroucke-Grauls C, Appelmelk B, Schenk B, Meuwissen S . Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl. 1997; 223:28-34. View

10.

Go M . What are the host factors that place an individual at risk for Helicobacter pylori-associated disease?. Gastroenterology. 1997; 113(6 Suppl):S15-20. DOI: 10.1016/s0016-5085(97)80005-4. View

11.

Mobley H . Helicobacter pylori factors associated with disease development. Gastroenterology. 1997; 113(6 Suppl):S21-8. DOI: 10.1016/s0016-5085(97)80006-6. View

12.

Romano M, Ricci V, Di Popolo A, Sommi P, Del Vecchio Blanco C, Bruni C . Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest. 1998; 101(8):1604-13. PMC: 508741. DOI: 10.1172/JCI1174. View

13.

Mezey E, Palkovits M . Localization of targets for anti-ulcer drugs in cells of the immune system. Science. 1992; 258(5088):1662-5. DOI: 10.1126/science.1333642. View

14.

Graham D, Go M . Helicobacter pylori: current status. Gastroenterology. 1993; 105(1):279-82. DOI: 10.1016/0016-5085(93)90038-e. View

15.

Jiang Q, Hiratsuka K, Taylor D . Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol Microbiol. 1996; 20(4):833-42. DOI: 10.1111/j.1365-2958.1996.tb02521.x. View

16.

Hahm K, Park I, Kim Y, Kim J, Cho S, Lee S . Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. Free Radic Biol Med. 1997; 22(4):711-6. DOI: 10.1016/s0891-5849(96)00406-6. View

17.

Sakagami T, Dixon M, ORourke J, Howlett R, Alderuccio F, Vella J . Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut. 1996; 39(5):639-48. PMC: 1383385. DOI: 10.1136/gut.39.5.639. View

18.

Roberts A . Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen. 1995; 3(4):408-18. DOI: 10.1046/j.1524-475X.1995.30405.x. View

19.

Hahm K, Lee K, Choi S, Kim J, Cho S, Yim H . Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am J Gastroenterol. 1997; 92(10):1853-7. View

20.

Warren J, Marshall B . Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983; 1(8336):1273-5. View